Similar Papers

Paper Title
Journal
Date
Author
Dynamics of Methylation Profiling in Response to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia
Shun Liao ... Dennis Kim
Blood | VOL. 130
Shun Liao, et. al.Shun Liao ... Dennis Kim
25 Jun 2021
Combined stereotactic radiosurgery and tyrosine kinase inhibitor therapy versus tyrosine kinase inhibitor therapy alone for the treatment of non-small cell lung cancer patients with brain metastases.
Guan-Ying Chiou ... Cheng-Chia Lee
Journal of Neurosurgery | VOL. 137
Guan-Ying Chiou, et. al.Guan-Ying Chiou ... Cheng-Chia Lee
01 Aug 2022
Resection Combined with TKI Therapy for Resectable Liver Metastases of Gastrointestinal Stromal Tumours: Results from Three National Centres in China
Qichen Chen ... Xinyu Bi
Journal of Gastrointestinal Surgery | VOL. 24
Qichen Chen, et. al.Qichen Chen ... Xinyu Bi
11 Jun 2019
Cost Effectiveness of Tyrosine Kinase Inhibitor (TKIs) Therapy in Chronic Myelogenous Leukemia (CML) in Comparison to Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Based on the Nationwide Inpatient Sample (NIS) Database from 2002 to 2011
Indumathy Varadarajan ... Michael Styler
Blood | VOL. 126
Indumathy Varadarajan, et. al.Indumathy Varadarajan ... Michael Styler
03 Dec 2015
View more papers

More From: Leukemia & Lymphoma

Paper Title
Journal
Date
Author
Matching-adjusted indirect comparisons of zanubrutinib (MAGNOLIA, BGB-3111-AU-003) versus ibrutinib (PCYC-1121) and rituximab (CHRONOS-3) in relapsed/refractory marginal zone lymphoma
Catherine Thieblemont ... Pier L Zinzani
Leukemia & Lymphoma | VOL. 66
Catherine Thieblemont, et. al.Catherine Thieblemont ... Pier L Zinzani
28 Jan 2025
Polatuzumab vedotin extravasation injury: a case report.
Sushila A Toulmin ... Esther E Freeman
Leukemia & lymphoma | VOL. -
Sushila A Toulmin, et. al.Sushila A Toulmin ... Esther E Freeman
25 Jan 2025
Presence of minimal residual disease determined by next-generation sequencing is not a reliable prognostic biomarker in children with acute lymphoblastic leukemia
Elizabeta Krstevska Bozhinovikj ... Aleksandar Dimovski
Leukemia & Lymphoma | VOL. ahead-of-print
Elizabeta Krstevska Bozhinovikj, et. al.Elizabeta Krstevska Bozhinovikj ... Aleksandar Dimovski
22 Jan 2025
Therapeutic approach to patients with early stage diffuse large B cell lymphoma: retrospective, multicenter, real-life study of the 'RTL' (regional Tuscan lymphoma network).
Emanuele Cencini ... Alberto Fabbri
Leukemia & lymphoma | VOL. -
Emanuele Cencini, et. al.Emanuele Cencini ... Alberto Fabbri
21 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.